Coronavirus antibodies might not be long-lasting, but the latest research has found new hope for battling the virus — your adaptive T cells. And it may lead the way to a vaccine.
You’d think geezers like me could rest a lot easier once a COVID-19 vaccine comes down the pike, but experts suggest it may not work much better than the annual flu shot.
The concept of herd immunity is a growing part of the conversation about resolving the coronavirus pandemic. Infectious-disease researcher Daniel Altmann, PhD, offers insights on what it really means.
The new VirScan test may be used to create vaccines, track disease outbreaks — and more.